Stephen A. Woski - Publications

Affiliations: 
The University of Alabama, Tuscaloosa, AL 
Area:
Organic Chemistry

19/36 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Han Y, Jiang L, Meany JE, Wang Y, Woski SA, Johnson MS, Nijhuis CA, Metzger RM. Verification and Temperature-Dependent Rectification by HBQ, the Smallest Unimolecular Donor-Acceptor Rectifier. Acs Omega. 7: 28790-28796. PMID 36033727 DOI: 10.1021/acsomega.2c01182  0.693
2022 Benitah A, Qualley DF, Woski SA. Substituent effects on indole universal bases in DNA. Nucleosides, Nucleotides & Nucleic Acids. 1-18. PMID 35921554 DOI: 10.1080/15257770.2022.2105354  0.763
2016 Meany JE, Johnson MS, Woski SA, Metzger RM. Surprisingly Big Rectification Ratios for a Very Small Unimolecular Rectifier. Chempluschem. 81: 1152-1155. PMID 31964106 DOI: 10.1002/Cplu.201600383  0.718
2016 Meany JE, Gerlach DL, Papish ET, Woski SA. Crystal structure of 4'-bromo-2',5'-dimeth-oxy-2,5-dioxo-[1,1'-biphen-yl]-3,4-dicarbo-nitrile [BrHBQ(CN)2] benzene hemisolvate. Acta Crystallographica. Section E, Crystallographic Communications. 72: 600-3. PMID 27375897 DOI: 10.1107/S2056989016005120  0.739
2016 Meany JE, Kelley SP, Rogers RD, Woski SA. Crystal structure of 4'-bromo-2,5-dihy-droxy-2',5'-dimeth-oxy-[1,1'-biphen-yl]-3,4-dicarbo-nitrile. Acta Crystallographica. Section E, Crystallographic Communications. 72: 667-70. PMID 27308015 DOI: 10.1107/S2056989016005715  0.753
2016 Meany JE, Kelley SP, Rogers RD, Woski SA. Crystal structure of 4′-bromo-2,5-dihydroxy-2′,5′-dimethoxy-[1,1′-biphenyl]-3,4-dicarbonitrile Acta Crystallographica Section E: Crystallographic Communications. 72: 667-670. DOI: 10.1107/S2056989016005715  0.748
2016 Meany JE, Gerlach DL, Papish ET, Woski SA. Crystal structure of 4'-bromo-2',5;-dimethoxy-2,5- dioxo-[1,1'-biphenyl]-3,4-dicarbonitrile [BrHBQ(CN)2] benzene hemisolvate Acta Crystallographica Section E: Crystallographic Communications. 72: 600-603. DOI: 10.1107/S2056989016005120  0.726
2016 Meany JE, Kelley SP, Metzger RM, Rogers RD, Woski SA. Crystal structure of 4,4'-dibromo-2',5'-dimethoxy-[1,1'-biphenyl]-2,5-dione (BrHBQBr) Acta Crystallographica Section E: Crystallographic Communications. 71: 1454-1456. DOI: 10.1107/S2056989015020472  0.709
2015 Meany JE, Kelley SP, Metzger RM, Rogers RD, Woski SA. Crystal structure of 4,4'-di-bromo-2',5'-dimeth-oxy-[1,1'-biphen-yl]-2,5-dione (BrHBQBr). Acta Crystallographica. Section E, Crystallographic Communications. 71: 1454-6. PMID 26870403 DOI: 10.1107/S2056989015020472  0.751
2007 MacKinnon KF, Qualley DF, Woski SA. Polycyclic aromatic hydrocarbons as universal bases in peptide nucleic acid Tetrahedron Letters. 48: 8074-8077. DOI: 10.1016/J.Tetlet.2007.09.019  0.761
2002 Frey KA, Woski SA. Fluoroaromatic universal bases in peptide nucleic acids. Chemical Communications (Cambridge, England). 2206-7. PMID 12397980 DOI: 10.1039/B205734D  0.385
1999 Challa H, Styers ML, Woski SA. Nitroazole universal bases in peptide nucleic acids. Organic Letters. 1: 1639-41. PMID 10836026 DOI: 10.1021/Ol990270Q  0.736
1999 Wichai U, Woski SA. Disiloxane-protected 2-deoxyribonolactone as an efficient precursor to 1,2-dideoxy-1-beta-aryl-D-ribofuranoses. Organic Letters. 1: 1173-5. PMID 10825968 DOI: 10.1021/Ol990813W  0.757
1999 Hacia JG, Novotny EA, Mayer RA, Woski SA, Ashlock MA, Collins FS. Design of modified oligodeoxyribonucleotide probes to detect telomere repeat sequences in FISH assays. Nucleic Acids Research. 27: 4034-9. PMID 10497268 DOI: 10.1093/Nar/27.20.4034  0.336
1999 Challa H, Woski SA. Incorporation and characterization of abasic and phenyl residues in peptide nucleic acids Tetrahedron Letters. 40: 8333-8336. DOI: 10.1016/S0040-4039(99)01781-5  0.739
1999 Challa H, Woski SA. Solution phase synthesis of potential DNA-binding molecules based on the PNA backbone Tetrahedron Letters. 40: 419-422. DOI: 10.1016/S0040-4039(98)02385-5  0.727
1998 Wichai U, Woski SA. An improved route to 1,2-dideoxy-beta-1-phenyl-D-ribofuranose. Bioorganic & Medicinal Chemistry Letters. 8: 3465-8. PMID 9934453 DOI: 10.1016/S0960-894X(98)00632-5  0.726
1998 Frazer JD, Horner SM, Woski SA. Synthesis of a novel pyrene-containing nucleoside and its incorporation into oligonucleotides Tetrahedron Letters. 39: 1279-1282. DOI: 10.1016/S0040-4039(97)10853-X  0.345
1992 Woski SA, Koreeda M. Synthesis of the putative active metabolites of the cyclopenta[a]phenanthrenes. Synthesis of the trans-3,4-dihydro 3,4-diol and syn-3,4-diol 1,2-epoxide derivatives of the mutagen 15,16-dihydrocyclopenta[a]phenanthren-17-one Journal of Organic Chemistry. 57: 5736-5741. DOI: 10.1021/Jo00047A030  0.536
Low-probability matches (unlikely to be authored by this person)
2019 Brown S, Lockart MM, Thomas CS, Bowman MK, Woski SA, Vincent JB. Molecular Structure of Binary Chromium(III)-DNA Adducts. Chembiochem : a European Journal of Chemical Biology. PMID 31472032 DOI: 10.1002/Cbic.201900436  0.298
1999 Speetjens JK, Parand A, Crowder MW, Vincent JB, Woski SA. Low-molecular-weight chromium-binding substance and biomimetic [Cr3O(O2CCH2CH3)6(H 2O)3]+ do not cleave DNA under physiologically-relevant conditions Polyhedron. 18: 2617-2624. DOI: 10.1016/S0277-5387(99)00166-7  0.283
1998 Hacia JG, Woski SA, Fidanza J, Edgemon K, Hunt N, McGall G, Fodor SP, Collins FS. Enhanced high density oligonucleotide array-based sequence analysis using modified nucleoside triphosphates. Nucleic Acids Research. 26: 4975-82. PMID 9776762 DOI: 10.1093/Nar/26.21.4975  0.268
2008 MacKinnon KF, Qualley DF, Woski SA. ChemInform Abstract: Polycyclic Aromatic Hydrocarbons as Universal Bases in Peptide Nucleic Acid. Cheminform. 39. DOI: 10.1002/CHIN.200803202  0.262
2003 Hepburn DD, Marcel Burney J, Woski SA, Vincent JB. The nutritional supplement chromium picolinate generates oxidative DNA damage and peroxidized lipids in vivo Polyhedron. 22: 455-463. DOI: 10.1016/S0277-5387(02)01369-4  0.254
2020 Brown S, Lockart MM, Thomas CS, Bowman MK, Woski SA, Vincent JB. Cover Feature: Molecular Structure of Binary Chromium(III)–DNA Adducts (ChemBioChem 5/2020) Chembiochem. 21: 575-575. DOI: 10.1002/Cbic.202000078  0.244
2005 Vincent JB, Woski SA. Cytochrome c: A Biochemistry Laboratory Course Journal of Chemical Education. 82: 1211. DOI: 10.1021/Ed082P1211  0.229
2000 Sun Y, Ramirez J, Woski SA, Vincent JB. The binding of trivalent chromium to low-molecular-weight chromium-binding substance (LMWCr) and the transfer of chromium from transferrin and chromium picolinate to LMWCr. Journal of Biological Inorganic Chemistry : Jbic : a Publication of the Society of Biological Inorganic Chemistry. 5: 129-36. PMID 10766445 DOI: 10.1007/S007750050016  0.226
2006 Honciuc A, Otsuka A, Wang YH, McElwee SK, Woski SA, Saito G, Metzger RM. Polarization of charge-transfer bands and rectification in hexadecylquinolinium 7,7,8-tricyanoquinodimethanide and its tetrafluoro analog. The Journal of Physical Chemistry. B. 110: 15085-93. PMID 16884220 DOI: 10.1021/Jp056910Q  0.219
2010 FRAZER JD, HORNER SM, WOSKI SA. ChemInform Abstract: Synthesis of a Novel Pyrene-Containing Nucleoside and Its Incorporation into Oligonucleotides. Cheminform. 29: no-no. DOI: 10.1002/chin.199822158  0.217
2016 Scalfani VF, Frantom PA, Woski SA. Replacing the Traditional Graduate Chemistry Literature Seminar with a Chemical Research Literacy Course Journal of Chemical Education. 93: 482-487. DOI: 10.1021/Acs.Jchemed.5B00512  0.216
2023 Brown S, Marchi S, Thomas CS, Hale AR, Lockart M, Bowman MK, Christou G, Woski SA, Vincent JB. Forming a chromium-based interstrand DNA crosslink: Implications for carcinogenicity. Journal of Inorganic Biochemistry. 251: 112439. PMID 38039560 DOI: 10.1016/j.jinorgbio.2023.112439  0.16
2021 Lankford E, Thomas CS, Marchi S, Brown S, Woski SA, Vincent JB. Examining the Potential Formation of Ternary Chromium-Histidine-DNA Complexes and Implications for Their Carcinogenicity. Biological Trace Element Research. PMID 33948897 DOI: 10.1007/s12011-021-02743-w  0.119
2023 Marchi S, Lankford E, Dorin B, Drummond E, Thomas SC, Woski SA, Vincent JB. Examining the Potential Formation of Ternary DNA Complexes with Chromium‑Cysteine, Chromium-Ascorbate, and Chromium-Glutathione and Implications for Their Carcinogenicity. Biological Trace Element Research. PMID 36662348 DOI: 10.1007/s12011-023-03573-8  0.114
1998 Woski SA. Bioorganic Chemistry:  Peptides and Proteins Edited by Sidney M. Hecht (University of Virginia). Oxford University Press:  New York. 1998. vii + 532 pp. $75.00. ISBN 0-195-08468-3. Journal of the American Chemical Society. 120: 12386-12386. DOI: 10.1021/ja985642p  0.112
1999 Speetjens J, Parand A, Crowder MW, Vincent JB, Woski SA. Low-molecular-weight chromium-binding substance and biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ do not cleave DNA under physiologically-relevant conditions Polyhedron. 18: 2617-2624. DOI: 10.1016/S0277-5387(99)00166-7  0.103
1999 Speetjens JK, Collins RA, Vincent JB, Woski SA. The nutritional supplement chromium(III) tris(picolinate) cleaves DNA. Chemical Research in Toxicology. 12: 483-7. PMID 10368310 DOI: 10.1021/tx9900167  0.093
Hide low-probability matches.